These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 28612596)

  • 1. Prognostic Value of the Neutrophil to Lymphocyte Ratio (NLR) in Lung Cancer Cases.
    Akinci Ozyurek B; Sahin Ozdemirel T; Buyukyaylaci Ozden S; Erdogan Y; Kaplan B; Kaplan T
    Asian Pac J Cancer Prev; 2017 May; 18(5):1417-1421. PubMed ID: 28612596
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of platelet to lymphocyte ratio and neutrophil to lymphocyte ratio is a useful prognostic factor in advanced non-small cell lung cancer patients.
    Wu G; Yao Y; Bai C; Zeng J; Shi D; Gu X; Shi X; Song Y
    Thorac Cancer; 2015 May; 6(3):275-87. PubMed ID: 26273373
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Neutrophil-to-lymphocyte ratio predicts the survival in patients with post-operative recurrence of non-small cell lung cancer].
    Wang X; Li K
    Zhonghua Zhong Liu Za Zhi; 2014 Apr; 36(4):298-302. PubMed ID: 24989918
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical significance of preoperative neutrophil-lymphocyte vs platelet-lymphocyte ratio in primary operable patients with non-small cell lung cancer.
    Zhang H; Xia H; Zhang L; Zhang B; Yue D; Wang C
    Am J Surg; 2015 Sep; 210(3):526-35. PubMed ID: 26105800
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prognostic importance of the nutritional status and systemic inflammatory response in non-small cell lung cancer.
    Yildirim M; Yildiz M; Duman E; Goktas S; Kaya V
    J BUON; 2013; 18(3):728-32. PubMed ID: 24065491
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prognostic Significance of Preoperative Neutrophil-Lymphocyte Ratios in Patients with Stage I Non-small Cell Lung Cancer After Complete Resection.
    Takahashi Y; Horio H; Hato T; Harada M; Matsutani N; Morita S; Kawamura M
    Ann Surg Oncol; 2015 Dec; 22 Suppl 3():S1324-31. PubMed ID: 26198075
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Neutrophil-lymphocyte and platelet-lymphocyte ratios as prognostic factors after stereotactic radiation therapy for early-stage non-small-cell lung cancer.
    Cannon NA; Meyer J; Iyengar P; Ahn C; Westover KD; Choy H; Timmerman R
    J Thorac Oncol; 2015 Feb; 10(2):280-5. PubMed ID: 25299234
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical significance of the neutrophil-lymphocyte ratio in venous thromboembolism patients with lung cancer.
    Go SI; Lee A; Lee US; Choi HJ; Kang MH; Kang JH; Jeon KN; Park MJ; Kim SH; Lee GW
    Lung Cancer; 2014 Apr; 84(1):79-85. PubMed ID: 24524817
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Systemic Immune-inflammation Index, Based on Platelet Counts and Neutrophil-Lymphocyte Ratio, Is Useful for Predicting Prognosis in Small Cell Lung Cancer.
    Hong X; Cui B; Wang M; Yang Z; Wang L; Xu Q
    Tohoku J Exp Med; 2015 Aug; 236(4):297-304. PubMed ID: 26250537
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Preoperative neutrophil-to-lymphocyte ratio plus platelet-to-lymphocyte ratio in predicting survival for patients with stage I-II gastric cancer.
    Sun X; Liu X; Liu J; Chen S; Xu D; Li W; Zhan Y; Li Y; Chen Y; Zhou Z
    Chin J Cancer; 2016 Jun; 35(1):57. PubMed ID: 27342313
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic impact of pretreatment neutrophil-to-lymphocyte ratio in castration-resistant prostate cancer patients treated with first-line docetaxel.
    Buttigliero C; Pisano C; Tucci M; Vignani F; Bertaglia V; Iaconis D; Guglielmini P; Numico G; Scagliotti GV; Di Maio M
    Acta Oncol; 2017 Apr; 56(4):555-562. PubMed ID: 28068151
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prognostic Significance of Combination of Preoperative Platelet Count and Neutrophil-Lymphocyte Ratio (COP-NLR) in Patients with Non-Small Cell Lung Cancer: Based on a Large Cohort Study.
    Zhang H; Zhang L; Zhu K; Shi B; Yin Y; Zhu J; Yue D; Zhang B; Wang C
    PLoS One; 2015; 10(5):e0126496. PubMed ID: 25950176
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Are neutrophil/lymphocyte ratio and platelet/lymphocyte ratio associated with prognosis in patients with HER2-positive early breast cancer receiving adjuvant trastuzumab?
    Ulas A; Avci N; Kos T; Cubukcu E; Olmez OF; Bulut N; Degirmenci M
    J BUON; 2015; 20(3):714-22. PubMed ID: 26214622
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Application of platelet/lymphocyte and neutrophil/lymphocyte ratios in early diagnosis and prognostic prediction in patients with resectable gastric cancer.
    Lian L; Xia YY; Zhou C; Shen XM; Li XL; Han SG; Zheng Y; Mao ZQ; Gong FR; Wu MY; Chen K; Tao M; Li W
    Cancer Biomark; 2015; 15(6):899-907. PubMed ID: 26444485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Platelet-lymphocyte ratio is an independent prognostic factor in patients with ALK-positive non-small-cell lung cancer.
    Han Y; Wang J; Hong L; Sun L; Zhuang H; Sun B; Wang H; Zhang X; Ren X
    Future Oncol; 2017 Jan; 13(1):51-61. PubMed ID: 27523323
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Is Onodera's prognostic nutritional index (OPNI) a prognostic factor in small cell lung cancer (SCLC)?
    Yenibertiz D; Ozyurek BA; Erdogan Y
    Clin Respir J; 2020 Aug; 14(8):689-694. PubMed ID: 32170830
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A Retrospective Cohort Study on Pretreated Neutrophil-to-Lymphocyte Ratio and Prognosis of Small Cell Lung Cancer: Evidence of Effect Modification by Chemotherapy Regimen.
    Liu F; Zhou S; Tan L; Jiang H; Huang Y
    Cancer Manag Res; 2020; 12():10341-10352. PubMed ID: 33116889
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neutrophil count is associated with survival in localized prostate cancer.
    Bahig H; Taussky D; Delouya G; Nadiri A; Gagnon-Jacques A; Bodson-Clermont P; Soulieres D
    BMC Cancer; 2015 Aug; 15():594. PubMed ID: 26292807
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Elevated preoperative inflammatory markers based on neutrophil-to-lymphocyte ratio and C-reactive protein predict poor survival in resected non-small cell lung cancer.
    Tomita M; Shimizu T; Ayabe T; Nakamura K; Onitsuka T
    Anticancer Res; 2012 Aug; 32(8):3535-8. PubMed ID: 22843942
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic significance of pretreatment laboratory parameters in combined small-cell lung cancer.
    Wang X; Jiang R; Li K
    Cell Biochem Biophys; 2014 Jul; 69(3):633-40. PubMed ID: 24554485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.